《滬深兩市》上證全日近低收 創板跌2.3% 寧德時代挫逾7% 醫藥股逆市揚
內地昨日(23日)新增本土確診病例55例,西安佔49例。人行今日(24日)進行100億人民幣(下同)7天期和100億14天期逆回購操作,利率均持平。人民幣兌美元中間價今下調41點,上證深成高開低走,創板跌幅顯着。A股午後沽壓未止,各指數跌穿早市低位,創板表現弱勢。滬深兩市成交額連續第46個交易日突破1萬億元。
上證低見3,612,全日跌25點或0.7%,近低收報3,618點;深成指跌153點或1%,收報14,710點;滬深300指數跌27點或0.6%,收報4,921點;創業板指數低見3,280,全日跌76點或2.3%,收報3,297點,成交2,535億元。上證深成全日成交分別爲4,763億元及6,555.5億元。
中資金融股無方向,工行(601398.SH)平收。建行(601939.SH)升0.3%。
內房股持續下跌,渝開發(000514.SZ)、大龍地產(600159.SH)、嘉凱城(000918.SZ)跌停。
汽車、鋰電池股走低,小康股份(601127.SH)跌停。亞星客車(600213.SH)、北汽藍谷(600733.SH)、江淮汽車(600418.SH)、長汽(601633.SH)、比亞迪(002594.SZ)跌3.6%至7.4%。寧德時代(300750.SZ)投資力泰鋰能,拓展鋰離子電池正極材料研發,惟股價急挫7.3%。
醫藥股逆市上揚,多隻股份漲停。廣生堂(300436.SZ)、紅日藥業(300026.SZ)、大理藥業(603963.SH)、濟州藥業(600566.SH)漲停。
貴州茅臺(600519.SH)續升,今日高開高走逆市升3.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.